SEC Info - Keurig Dr Pepper Inc. - ‘8-K/A’ for 10/7/22

SEC Info℠

Home

Help

Please Sign In

Keurig Dr Pepper Inc. – ‘8-K/A’ for 10/7/22

On: Wednesday, 11/23/22, at 5:09pm ET · For: 10/7/22 · Accession #: 1418135-22-26 · File #: 1-33829

  As Of               Filer                 Filing    For·On·As Docs:Size

11/23/22  Keurig Dr Pepper Inc.             8-K/A:5    10/07/22   10:226K

Amendment to Current Report — Form 8-K

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K/A       Amendment to Current Report                         HTML     35K 
 5: R1          Cover Document                                      HTML     47K 
 8: XML         IDEA XML File -- Filing Summary                      XML     11K 
 6: XML         XBRL Instance -- kdp-20221007_htm                    XML     22K 
 7: EXCEL       IDEA Workbook of Financial Reports                  XLSX      8K 
 3: EX-101.LAB  XBRL Labels -- kdp-20221007_lab                      XML     70K 
 4: EX-101.PRE  XBRL Presentations -- kdp-20221007_pre               XML     34K 
 2: EX-101.SCH  XBRL Schema -- kdp-20221007                          XSD     10K 
 9: JSON        XBRL Instance as JSON Data -- MetaLinks               12±    17K 
10: ZIP         XBRL Zipped Folder -- 0001418135-22-000026-xbrl      Zip     43K

‘8-K/A’ — Amendment to Current Report

This is an HTML Document rendered as filed. [ Alternative Formats ]

iX: C: C:

kdp-20221007

i 0001418135 i TRUE00014181352022-10-072022-10-07

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM i 8-K/A

(AMENDMENT NO. 1)

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): i October 7, 2022

i Keurig Dr Pepper Inc.

(Exact name of registrant as specified in its charter)

i Delaware

i 001-33829

i 98-0517725

(State or other jurisdiction of incorporation)

(Commission File Number)

(IRS Employer Identification No.)

i 53 South Avenue, i Burlington, i Massachusetts i 01803

(Address of principal executive offices, including zip code)

i 781- i 418-7000

(Registrant’s telephone number including area code)

Not Applicable

(Former name or former address if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

i ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

i ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

i ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

i ☐ Pre-commencement communications pursuant to Rule 13e-14(c) under the Exchange Act (17 CFR 240.13e-14(c))

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company i ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol

Name of each exchange on which registered

i Common stock

i KDP

i Nasdaq Stock Market LLC

Introductory Note

This Amendment No. 1 (this “Amendment”) amends the Current Report on Form 8-K filed with the Securities and Exchange Commission (the “SEC”) on October 13, 2022 (the “Original Form 8-K”) by Keurig Dr Pepper Inc. (“KDP” or the “Company”), to describe the separation and release agreement (the “Separation Agreement”) entered into between the Company and Tony Milikin, the Company’s former Chief Supply Chain Officer and a named executive officer in the Company’s 2022 Proxy Statement, who departed the Company effective as of October 28, 2022.

This Form 8–K/A does not modify or update other disclosures in, or exhibits to, the Original Form 8–K.

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Effective as of November 18, 2022, the Company and Mr. Milikin entered into the Separation Agreement. In accordance with the Company’s Executive Severance Plan, as amended effective July 29, 2022, the Separation Agreement provides that Mr. Milikin will receive severance benefits consistent with his Qualifying Termination without Cause, which is an amount equal to 1.5 times the sum of Mr. Milikin’s annual base salary and annual target bonus, payable in substantially equal installments over 18 months, as well as Company-provided outplacement services. In addition, in recognition of his contributions to the Company, as well as to make Mr. Milikin whole for certain compensation that he had forgone with his prior employer upon hire by the Company in September 2021, the Remuneration and Nominating Committee of the Company’s Board of Directors also approved a one-time lump sum payment in the gross amount of $2,000,000 to be paid to Mr. Milikin subject to his execution of and compliance with the Separation Agreement.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.